Research


Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program

with Sonya Das, Contemporary Clinical Trials 62 (2017) 168–174

View abstract

The Growth of Relative Wealth and the Kelly Criterion

with H. Allen Orr and Ruixun Zhang

View abstract

Accelerating Biomedical Innovation: A Case Study of the SPARK Program at Stanford University, School of Medicine

with Esther S. Kim, Paige M.C. Omura, Drug Discovery Today 22:7 (2017)

View abstract

Stop-loss Strategies with Serial Correlation, Regime Switching, and Transaction Costs

with Alexander Remorov, Journal of Financial Markets 34 (2017) 1–15

View abstract

Use of Bayesian Decision Analysis to Minimize Harm in Patient-Centered Randomized Clinical Trials in Oncology

with Vahid Montazerhodjat; Shomesh E. Chaudhuri; Daniel J. Sargent, JAMA Oncology (2017)

View abstract

Hedge Fund Holdings and Stock Market Efficiency

with Charles Cao, Bing Liang, and Lubomir Petrasek, Review of Asset Pricing Studies rax015 (2017)

View abstract

New directions for the FDA in the 21st century

Biostatistics

View abstract

Moore’s Law Vs. Murphy’s Law in the Financial System: Who’s Winning?

Journal of Investment Management 15 (2017), 17–38.

View abstract

Buying Cures vs. Renting Health: Financing Healthcare via Consumer Loans

with Vahid Montazerhodjat and David Weinstock, Science Translational Medicine 8(2016), 327ps6

View abstract

The Wisdom of Twitter Crowds: Predicting Stock Market Reactions to FOMC Meetings via Twitter Feeds

with Pablo D. Azar, Journal of Portfolio Management 42(2016), 123–134.

View abstract

Follow me on © 2017 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design